Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
---|
07/25/2001 | EP0649312B1 Anthracycline conjugates, their preparation and their use as antitumor agents |
07/25/2001 | CN1305487A Benzo (b) thiepine-1, 1-dioxide derivatives, method for production thereof, medicaments containing these compounds and their use |
07/25/2001 | CN1305486A Novel compounds derived from alpha-D-xylose, preparation method and therapeutic use |
07/25/2001 | CN1305469A Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
07/24/2001 | US6265555 Generating preferential nervous system protein in solution; disperse ganglioside material in ethanol solution, heat, remove protein precipitate, cool supernatant, recover protein of interest |
07/19/2001 | WO2001051499A1 METHODS FOR SYNTHESIS OF α-D-GAL (1→3) GAL-CONTAINING OLIGOSACCHARIDES |
07/19/2001 | WO2001051498A1 Novel techniques for the preparation and crystallization of 4-o-beta-d-galactopyranosyl-d-gluconic acid |
07/19/2001 | WO2001051497A1 Novel bisphosphonates and uses thereof |
07/19/2001 | WO2001051060A1 Prevention and treatment of endotoxemia and related complications associated with surgery |
07/19/2001 | WO2001051057A2 Glycosides and orthoester glycosides of glucocorticoids and uses thereof |
07/19/2001 | WO2001051003A2 Use of lipid conjugates in the treatment of disease |
07/19/2001 | WO2001002020A3 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
07/19/2001 | CA2396966A1 Methods for synthesis of .alpha.-d-gal (1.fwdarw.3) gal-containing oligosaccharides |
07/19/2001 | CA2392731A1 Prevention and treatment of endotoxemia and related complications associated with surgery |
07/18/2001 | EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
07/18/2001 | CN1303858A Tetrahydroxydiphenylethylene glycosides compounds for preventing and curing angiocardiopathy and cerebrovascular diseases |
07/17/2001 | US6262257 Selective ion- and neutral molecule-binding agents forming supramolecular ensembles, and ion- and neutral molecule-separation agents |
07/17/2001 | US6261813 Two step enzymatic acylation |
07/17/2001 | CA2029006C Dicarboxylic acid oxidation products |
07/12/2001 | WO2001049698A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
07/12/2001 | CA2395660A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
07/11/2001 | EP1114046A1 Interleukin-5 inhibiting 6-azauracil derivatives |
07/11/2001 | EP1113791A2 Bioflavonoid as blood glucose level lowering agent |
07/11/2001 | EP1113726A1 Composition containing neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-related diseases |
07/10/2001 | US6258786 Antitumor agents of anthracycline glycosides |
07/10/2001 | US6258784 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
07/10/2001 | US6258360 Benzoate conjugates; antitumor agents |
07/05/2001 | WO2001047941A2 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use |
07/05/2001 | WO2001047940A1 Benzophenone glycopyranosides, preparation and therapeutic use |
07/05/2001 | WO2000026223A8 Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents |
07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
07/05/2001 | US20010006956 Maltitol crystals of particular forms, crystalline compositions containing them and processes for their preparation |
07/05/2001 | CA2395561A1 Benzophenone glycopyranosides, preparation and therapeutic use |
07/05/2001 | CA2395557A1 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use |
07/04/2001 | CN1301703A Extracting technology for lincomycin |
07/03/2001 | US6255297 Salicylic acid derivatives and their use in cosmetic or dermatological compositions |
07/03/2001 | US6254526 Hearing aid having hard mounting plate and soft body bonded thereto |
07/03/2001 | CA2006222C Enhanced chemiluminescence from 1,2-dioxetanes through energy transfer to tethered fluorescers |
06/28/2001 | WO2001046385A1 A new fungal strain acremonium sp. mt70646 (kctc 8973p), novel compounds produced by this strain and their use |
06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
06/28/2001 | US20010005715 Comprising the condensation reaction product of an aldose such as glucose and a benzene containing one or more hydroxy, amino, carboxy, or sulfonyl groups; use such as iron, zinc or manganese complex fertilizers for plants |
06/27/2001 | EP1111065A2 Production of saccharide carboxylic acids |
06/27/2001 | CN1301157A Sustained release preparations |
06/26/2001 | US6252060 Antiviral liponucleosides: treatment of hepatitis B |
06/26/2001 | US6251858 Derivatives of glycosylamine in which the oligosides are fixed on at least one molecule, matrix or particle |
06/21/2001 | WO2001044247A2 Agents and methods for the treatment of proliferative diseases |
06/19/2001 | CA2191129C Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin |
06/14/2001 | WO2001042264A1 Method for the synthesis of sialylated oligosaccharide donors |
06/14/2001 | WO2001042262A2 Antithrombotic compound |
06/14/2001 | WO2001042179A1 Compounds which mimic the chemical and biological properties of discodermolide |
06/14/2001 | CA2393968A1 Compounds which mimic the chemical and biological properties of discodermolide |
06/13/2001 | EP0688331B1 New sulfated lyso-ganglioside derivatives |
06/13/2001 | DE19848548C2 Verfahren zur Aufarbeitung verunreinigter Fettalkohol-Gemische Method for processing contaminated fatty alcohol mixtures |
06/13/2001 | CN1299367A 2''-deoxy hygromycin derivatives |
06/13/2001 | CN1299366A 5-imino-13-doxy anthracycline derivatives, their uses, and processes for preparing them |
06/13/2001 | CN1299365A Hygromycin A derivatives |
06/13/2001 | CN1067082C Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
06/12/2001 | US6245902 C-glycoside analogs and methods for their preparation and use |
06/12/2001 | US6245821 Alkyl polyglycosides-based compositions and uses thereof, and preparation of stable emulsions with improved whiteness |
06/12/2001 | US6245745 Bactericides and antiprotozoa agents |
06/12/2001 | US6245744 Antilipemic agents |
06/12/2001 | CA2046857C Morpholinyl derivatives of doxorubicin and process for their preparation |
06/07/2001 | WO2001040232A1 Chlorophyll and bacteriochlorophyll esters, and their preparation |
06/07/2001 | WO2001039726A2 Antimicrobial 2-deoxystreptamine compounds |
06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
06/07/2001 | CA2392989A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
06/05/2001 | US6242616 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
06/05/2001 | US6242425 Sinapic acid glycoside intermediates |
06/05/2001 | US6241995 Polygala senega compositions and methods of use |
06/05/2001 | CA2130028C Method for determining sugar chain structure |
05/31/2001 | WO2001038339A1 Antimitotic compounds |
05/31/2001 | WO2001038337A2 Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries |
05/31/2001 | WO2001037843A1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
05/31/2001 | WO2001037790A1 Use of alkyl- and/or alkenyloligoglycoside fatty acid esters for improving the sensory evaluation of emulsions |
05/31/2001 | DE19956606A1 Use of alkyl- and/or alkenyl-oligoglycoside fatty acid esters in emulsions, useful in cosmetic or pharmaceutical creme, lotion or salve |
05/31/2001 | CA2394874A1 Antimitotic compounds |
05/31/2001 | CA2392356A1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
05/31/2001 | CA2391966A1 Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries |
05/30/2001 | EP1102783A1 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom |
05/30/2001 | EP1102780A2 Solid phase synthesis of thio-oligosaccharides |
05/30/2001 | EP1102779A2 Treatment of bacterial infections |
05/30/2001 | EP1102592A1 Coumarin and related aromatic-based polymeric prodrugs |
05/30/2001 | EP0804450B1 Novel method for making palatinitol |
05/30/2001 | EP0804449B1 Novel method for making palatinitol |
05/30/2001 | CN1066455C Secomacrolides from class of erythromycins and process for their preparation |
05/30/2001 | CN1066454C Physiologically active substances of plant, process for preparation thereof, and utilities thereof |
05/29/2001 | US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
05/29/2001 | US6238668 Administering polysaccharide |
05/29/2001 | CA2156717C Solution and solid-phase formation of glycosidic linkages |
05/25/2001 | WO2001036435A1 Glucofuranoses |
05/25/2001 | WO2001036433A2 Synthetic lipid-a analogs and uses thereof |
05/24/2001 | CA2290316A1 Novel source of eleutherobin and related antimitotic diterpenes |
05/23/2001 | CN1296011A Purine L-nucleoside, its analogue and use thereof |
05/22/2001 | US6235720 Acid-functionalized saccharide polymers |
05/22/2001 | US6235702 Aqueous nacreous lustre concentrate |
05/17/2001 | WO2001034617A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
05/17/2001 | WO2001034207A1 Gene carriers |
05/17/2001 | WO2001034176A1 A method and composition for treating prostate cancer |
05/17/2001 | WO2000056267A8 Methods and compositions for the manufacture of c-3' and c-4' anthracycline antibiotics |
05/17/2001 | DE19943496C1 Direkt verpressbarer Rohstoff für Komprimate Directly compressible material for compressed |